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Abstract
Background: Oxidative stress and large amounts of nitric oxide (NO) have been implicated in the pathophysiology
of neuronal injury and neurodegenerative disease. Recent studies have shown that (-)-epigallocatechin gallate
(EGCG), one of the green tea polyphenols, has potent antioxidant effects against free radical-mediated lipid
peroxidation in ischemia-induced neuronal damage. The purpose of this study was to examine whether EGCG
would attenuate neuronal expression of NADPH-d/nNOS in the motor neurons of the lower brainstem following
peripheral nerve crush. Thus, young adult rats were treated with EGCG (10, 25, or 50 mg/kg, i.p.) 30 min prior to
crushing their hypoglossal and vagus nerves for 30 seconds (left side, at the cervical level). The treatment (pre-
crush doses of EGCG) was continued from day 1 to day 6, and the animals were sacrificed on days 3, 7, 14 and 28.
Nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d) histochemistry and neuronal nitric oxide
synthase (nNOS) immunohistochemistry were used to assess neuronal NADPH-d/nNOS expression in the
hypoglossal nucleus and dorsal motor nucleus of the vagus.
Results: In rats treated with high dosages of EGCG (25 or 50 mg/kg), NADPH-d/nNOS reactivity and cell death of
the motor neurons were significantly decreased.
Conclusions: The present evidence indicated that EGCG can reduce NADPH-d/nNOS reactivity and thus may
enhance motor neuron survival time following peripheral nerve injury.
Background
Peripheral nerve injury (PNI) produces numerous mor-
phological, physiological, and biosynthetic changes in the
damaged neurons [1-3]. Damage caused by PNI is asso-
ciated with a variety of mechanisms, especially oxidative
stress and subsequent massive production of oxygen-
derived free radicals, which are thought to play a major
role in neurological disorders [4]. First identified as the
endothelium-derived relaxing factor [5,6], nitric oxide is
a short-lived free radical and gaseous biological messen-
g e rp r o d u c e db yn i t r i co x i d es y n t h a s e( N O S ) .T h i s
enzyme catalyzes the oxidation of L-arginine and nicoti-
namide adenine dinucleotide phosphate (NADPH) by O2
to yield L-citrulline and NO [7]. Three distinct NOS iso-
forms have been described: inducible (iNOS), endothelial
(eNOS), and neuronal (nNOS) [8]. In the nervous system,
free radical gas plays an important role in the regulation
of physiological activities ranging from synaptic plasticity
to neuroendocrine functions [9]. NO combines rapidly
with superoxide to form peroxynitrite, a potent oxidizing
agent with cytotoxic actions [10-12]. Previous studies
have indicated that PNI in adult animals results in dra-
matic up-regulation of nitric oxide synthase in certain
types of central and peripheral neurons that normally
lack or hardly ever express the enzyme [13-18]. The
injury-induced expression of NOS seems to signal the
impending death of lesioned cells, as the enzyme acts as
a killer protein by producing neurotoxic levels of NO
[19-28]. Accordingly, numerous studies have examined,
in various models of injury, the possibility of oxygen free
radical scavengers as therapeutic agents for oxidative
neuronal damage [22,26,29].
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lar beverages in the world because of its attractive flavor
and aroma. It contains an abundance of so-called ‘green
tea polyphenols (GTPs), typically flavonoids or catechins,
which are polyphenolic complexes with potential free
radical scavenger activity. Many studies have shown that
GTP can scavenge reactive oxygen species (ROS) such as
hydroxyl radical (·OH), hydrogen peroxide (H2O2), and
superoxide anion (O2
-) as well as reactive nitrogen spe-
cies (RNS) such as nitric oxide (·NO) and peroxynitrite
(ONOO
-) in many systems. GTP also acts to protect cells
from damage induced by the free radicals in the gaseous
p h a s e[ 3 0 - 3 5 ] .G r e e nt e ac o n t a i n sm a n yp o l y p h e n o l i c
compounds, including (-)-epigallocatechin gallate
(EGCG), (-)-epigallocatechin (EGC), (-)-epicatechin gal-
late (ECG), and (-)-epicatechin (EC). Of these, EGCG is
the most abundant and with two triphenolic groups, it is
the most effective antioxidant [36,37]. Although the
mechanisms of EGCG’s antioxidant activity remain
unclear, pharmacological studies have identified several
antioxidant properties such as: (1) blockade of nNOS and
iNOS induction [34,38,39] and (2) scavenging of free
radicals or attenuation of lipid peroxidation [36,37,40].
Thus, EGCG is expected to be neuroprotective.
To our knowledge, the potential effects of EGCG on
NOS activity and neuronal damage following nerve injury
in vivo remain to be explored. Notably, most previous stu-
dies concerning the effects of EGCG on NOS activity are
biochemical rather than morphological. Thus, we carried
out a morphological study using nicotinamine adenine
dinucleotide phosphate-diaphorase (NADPH-d) histo-
chemistry along with nNOS immunohistochemistry to
explore the time-course of nNOS expression in the hypo-
glossal nucleus (HN) and dorsal motor nucleus (DMN) of
the vagus in rats subjected to peripheral nerve crush injury
(PNCI) and to elucidate the effect of post-PNCI EGCG
treatment on motor neurons in the lower brainstem.
Methods
Treatment of experimental animals
Adult male Wistar rats (n = 80) weighing 200 - 250 g
were used and obtained from the Laboratory Animal
Center of the National Taiwan University. We followed
the Guide for the Care and Use of Laboratory Animals
(1985) as stated in the United States NIH guidelines
(NIH publication no.86-23) to treat animals for this study
including the care, housing, handling and experimental
procedures. All the experiments were approved by our
Laboratory Animal Center, China Medical University,
Taiwan. All efforts were made to minimize both the ani-
mal suffering and the number of animals used for this
investigation.
The experimental animals were anesthetized with
an intramuscular (i.m.) injection of mixtures of zoletil
(30 mg/kg) and xylazine (10 mg/kg). After anesthesia, the
left vagus and the hypoglossal nerves were subjected to
crush injury by clamping with a small hemostatic forceps
for 30 s; for the former, the level of clamping was mid-cer-
vical, whereas for the latter, right below the tendon of the
digastric muscle. In sham-operated animals (controls),
similar procedures were carried out except both of the left
side nerves remained intact. The experimental animals
were divided into four groups: I, II, III, and IV (10, 25,
50 mg/kg EGCG-pretreatment + PNCI and PNCI only,
respectively). Previous in vivo studies have demonstrated
that EGCG can pass the blood-brain barrier and reach the
brain parenchyma [34,38,41,42]. Animals in each group
were therefore received daily intraperitoneal injections of
EGCG or normal saline for successive six days with the
last injection at 30 min before PNCI. Different doses (10,
25, or 50 mg/kg body weight dissolved in normal saline) of
EGCG (cat No.E4143, Sigma-Aldrich, St Louis, MO, USA)
were applied in the present study. Each experimental
group was subdivided into four groups (n = 5) and sacri-
ficed at 3, 7, 14, and 28 days. All the experimental animals
were housed under the same conditions (controlled tem-
perature [22°C] and 12-h light/dark cycle) and given free
access to food and water ad libitum.
Perfusion and tissue preparation
At each time point, rats were deeply anesthetized with
mixtures of zoletil (30 mg/kg) and xylazine (10 mg/kg)
and perfused transcardially with 100 ml of Ringer’s solu-
tion followed by 300 ml of 4% paraformaldehyde in 0.1
M phosphate buffer (PB), pH 7.4. After perfusion, the
brainstem and its nuclei were quickly removed, rinsed
in 0.1 M PB, and transferred through a series of increas-
ing concentrations of sucrose buffer (10 - 30%) for cryo-
protection at 4°C overnight. Serial 30-μm thick sections
of the brainstem were cut transversely with a cryostat
on the following day and were alternately placed at a
distance of 120 μm apart into four-well dishes. Sections
collected in the first and second wells were processed
for NADPH-d histochemistry and counterstained with
neutral red; sections in the third well were processed for
nNOS immunohistochemistry and those in the fourth
well were processed for nNOS immunofluorescence
labeling combined with NADPH-d histochemistry.
NADPH-d histochemistry
NADPH-d used as a selective marker for nNOS as
described previously [21,27,43,44]. Briefly, sections in
the first two wells were incubated with NADPH-d med-
ium (0.1 mg/ml nitroblue tetrazolium, 1 mg/ml
b-NADPH, and 0.3% Triton X-100 in 0.1 M PB [pH
7.4]) for 1 h at 37°C, washed several times in 0.1 M PB
to terminate the reaction. For counting neuronal num-
bers, sections from the second well were further
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graded series of alcohols, cleared with xylene, and cover-
slipped with Permount.
nNOS immunohistochemistry
Sections in the third well were rinsed in 0.01 M phos-
phate buffered saline (PBS), pH 7.4, treated with 0.01 M
PBS containing 10% methanol and 3% hydrogen peroxide
for 1 h to abolish the endogenous peroxidase activity,
rinsed 3 times with PBS, and incubated with medium
containing 3% normal horse serum, 2% bovine serum
albumin, and 0.1% Triton X-100 for 1 h. The reacted sec-
tions were then washed several times with PBS, incubated
with antibody to nNOS (1:100; Santa Cruz Biotechnol-
ogy, Burlingame, CA, USA) for 24 h at 4°C, treated with
biotinylated secondary antibody (1:200; Vector Labora-
tories, Burlingame, CA, USA) for 1 h at room tempera-
ture, and incubated with Streptavidin/HRP (DAKO A/S,
Glostrup, Denmark). The signal was developed with dia-
minobenzidine (a peroxidase substrate).
Colocalization of nNOS and NADPH-d reactivity
Colocalization of NADPH-d and nNOS was detected by
immunofluorescence labeling of nNOS followed by histo-
chemical staining for NADPH-d [21,27,43,44]. Sections
in 4-well dishes were rinsed in 0.01 M PBS, incubated in
medium containing 3% normal goat serum, 2% bovine
serum albumin, and 0.1% Triton X-100 for 1 h to block
nonspecific binding, rinsed with PBS, and incubated with
mouse monoclonal antibody against nNOS (1:100; Santa
Cruz Biotechnology) for 24 h at 4°C. The reacted sections
were then treated with fluorescein isothiocyanate (FITC)-
conjugated anti-rabbit secondary antibody (1:200; Vector
Laboratories) for 2 h at room temperature, washed
several times with PBS, and coverslipped with buffered
glycerin to prevent fading. The tissue slides were photo-
graphed using a ZEISS fluorescence microscope equipped
with an appropriate excitation filter (450-490 nm) for
observing FITC-labeled nNOS-immunoreactive neurons.
After photographing, the sections were again washed sev-
eral times again in 0.1 M PB, processed for NADPH-d
histochemistry (as described above), rapidly dehydrated
through a graded series of alcohols, cleared with xylene,
and coverslipped with Permount.
Quantitative study and image analysis
In each animal, 20-30 sections representing the entire
length of the HN and DMN (extending from the obex
1.8 mm caudally and 1 mm rostrally) were collected
for NADPH-d histochemistry and neutral red counter-
staining and cell counting. To avoid bias for the
counts, large neurons (25-50 μm) with clearly outlined
nuclei but not small motor neurons were counted
due to the latter could not be distinguished from
interneurons being 10-18 μm in diameter. Both the
NADPH-d positive and negative (neutral red-counter-
stained) cells in the HN and DMN, either ipsilateral or
contralateral to the nerve crush site, were counted and
summed to present the total number of cells in 20-30
sections (unit volume, u). The labeling percentage was
calculated by dividing the number of NADPH-d(+)
neurons on the lesion side by the total number of neu-
rons on the same side. To confirm the coexistence of
NADPH-d(+) and nNOS(+) neurons, double-labeled
neurons in the HN and DMN of the same sections
were counted on the photomicrographs (data not
shown). Cells containing nNOS were counted in the
sections processed for NADPH-d histochemistry since
neuronal NADPH-d is a reliable marker of nNOS
[21,43]. Besides, the results of neuronal staining in sec-
tions stained for NADPH-d are usually better than
nNOS, which in turn facilitates computer-assisted
quantitative assessment. Labeling intensity of NADPH-
d(+) neurons was quantified using a computer-based
image analysis system (MGDS) and Image Pro-Plus
software (Media Cybernetics, Silver Spring, MD, USA).
Labeled sections were scanned at 100 × magnification
in bright field using a digital camera mounted on a
ZEISS microscope and the images were displayed on a
high-resolution monitor. Up to 100 cells per section
were measured along the entire length of the HN and
DMN. At 100 × magnification, the cytoplasmic optical
density (OD), which was used as an index of labeling
intensity, in NADPH-d(+) neurons was measured by
tracing the contour of the labeled soma in digitized
images. The background OD in each section was
measured by averaging five random polygons (area of
polygon = 150 μm
2) within the neuropil of the corre-
sponding HN and DMN regions on the non-lesioned
side. The staining intensity in a tissue section reflected
the amount of enzyme activity. Thus, all parameters
were controlled using methods to ensure consistent
gray level adjustment, histogram stretch, and minimal
optical density. To avoid introducing bias, two obser-
vers blinded to the animal treatment group counted
cells in the NADPH-d stained sections and evaluated
the data from image analysis of HN and DMN
neurons.
Statistical analysis
All data of this study were expressed as mean ± SEM and
statistical significance was determined with a commercially
available software package (SPSS version 12; SPSS, Chi-
cago, IL). Between-group differences in the percentage
and OD of NADPH-d positive neurons at various time
points, with or without EGCG treatment, were evaluated
using one-way analysis of variance (ANOVA) followed by
LSD post hoc test. The data collected in experimental
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pretreated versus control non-treated group) were further
analyzed using Student’s t test. Statistical difference was
considered significant if p < 0.05.
Control experiments
Some negative controls were included to ensure the
validity of the NADPH-d histochemical and nNOS
immunohistochemical results. Thus, the medium with-
out b- N A D P Hw a su s e da st h ec o n t r o li nN A D P H - d
staining protocol, whereas media without primary or
secondary antibodies were used as controls in nNOS
immunochemical procedure.
Results
NADPH-d/nNOS colocalization studies
Labeling for both nNOS and NADPH-d showed that the
majority of the NADPH-d positive neurons in the HN
and DMN were also positive for nNOS (Figure 1). The
distribution of nNOS-positive neurons in the brainstem
motor nuclei paralleled that of NADPH-d positive neu-
rons. The time course of PNCI-induced nNOS expres-
s i o ni nt h eH Na n dD M No nt h el e s i o ns i d ec o i n c i d e d
with that of PNCI-induced NADPH-d expression. Since
the NADPH-d histochemical method was sensitive and
specific, it was used for both qualitative and quantitative
analyses. No NADPH-d and nNOS positive neurons were
detected in the HN or the DMN of negative control rats.
NADPH-d/nNOS expression in the hypoglossal nucleus of
EGCG-treated rats following PNCI
In sham-operated groups of both non-treated and EGCG-
treated rats, no NADPH-d/nNOS positive [NADPH-d/
nNOS(+)] neurons were found on either side of the hypo-
glossal nucleus (HN). In non-treated rats subjected to
PNCI, NADPH-d/nNOS(+) neurons were first detected in
the HN at 3 days, with their number reaching a peak at 7
days (p < 0.05 vs. various time points; Figures 2A, 3A and
4; Table 1). The percentage of NADPH-d/nNOS(+) neu-
rons increased steeply from 4.92 ± 0.29% at 3 days to
28.64 ± 0.93% at 7 days after PNCI (Figure 4) but then
declined to 19.45 ± 0.95% and 3.69 ± 0.28% at 14 and
28 days, respectively, in rats with longer survival times
( F i g u r e s2 D ,3 Da n d4 ) .I ti sa l s ot r u ef o rt h ec h a n g e so f
cell total number that showed an increased population of
cells at various time points and reached the climax at 7
days (370 ± 9 cell/u; Table 1) after PNCI. The distribution
of NADPH-d/nNOS(+) neurons was random (Figures 2
and 3) and, at 3 days after PNCI, the staining intensity of
most labeled neurons was weak, but gradually enhanced
to 292 ± 35% above background values at 7 days following
PNCI (Figure 5). At the same time, shrunken NADPH-d
intensely-labeled neurons occurred (Figures 2 and 3).
In rats receiving high dosages of EGCG (25 and
50 mg/kg) treatment then subjected to PNCI, their
staining pattern of NADPH-d/nNOS was paralleled to
those of non-treated ones, but their total number and
Figure 1 NADPH-d/nNOS colocalization studies. Fluorescence (A, C) and light (B, D) photomicrographs showing nNOS(+) (A, C) and NADPH-d
(+) (B, D) labeled neurons on the lesioned side of the HN (A, B) and DMN (C, D) of rats following crush injury of left vagus and hypoglossal
nerves. Note that a most of nNOS(+) neurons (arrows in A-D) contain NADPH-d in the HN and DMN. Scale bar = 50 μm.
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lower than those of non-treated groups (p <0 . 0 5 ,
Figures 2, 3 and 4, Table 1). Similarly, EGCG-treated
(25 and 50 mg/kg) rats at various time points after
PNCI showed a marked increase in the total number of
NADPH-d negative cells (p < 0.05 vs. non-treated
g r o u p s ;T a b l e1 ) .T h ep e r c e n t a g eo fN A D P H - d / n N O S
(+) neurons was slightly increased from 3.82 ± 0.27%
and 2.26 ± 0.65% at 3 days to 17.52 ± 0.70% and 8.33 ±
0.76% at 7 days respectively in EGCG-treated (25 and
50 mg/kg) rats after PNCI (Figure 4). In EGCG-treated
rats killed at longer survival periods after PNCI, the per-
centage of NADPH-d/nNOS(+) neurons was gradually
decreased at 14 days and approached to zero at 28 days
(Figure 4). EGCG treatment did not alter NADPH-d/
nNOS(+) neuron distribution but statistical evaluation
revealed that the staining intensity of NADPH-d/nNOS
appeared to be lower in the treated groups than non-
treated ones at all time intervals post-injury (p <0 . 0 5 ,
Figure 5). Low-dose (10 mg/kg) EGCG treatment had
no effect on enzyme amount and expression (Figures
2B, D, 3B, D, 4 and 5; Table 1).
Figure 2 Histochemistry of NADPH-d in the HN and DMN. Light photomicrographs showing the injury-induced NADPH-d reactivity in the
lesioned side of the HN and DMN at 7 (A, B, C) and 14 (D, E, F) days after PNCI. NADPH-d staining is barely detected in HN and DMN neurons
in the contralateral intact side of the nuclei (the right side of each figure). Note the marked increase in NADPH-d reactivity both in terms of
staining intensity and number of labeled neurons at 7 days in the HN and DMN after PNCI (A, B, C). Also note that the population of NADPH-d
(+) neurons in the HN is reduced at 14 days after PNCI, whereas that in the DMN tends to increase (D, E, F) when compared those at 7 days
post PNCI. Some shrunken cells (D, arrows) are found to display intense NADPH-d reactivity. In rats receiving EGCG treatment at high dose (50
mg/kg, C, F), the diaphorase reactivity and the number of positive neurons are noticeably reduced in relation to those of non-treated rats (A, D)
or animals treated with lower dose EGCG (10 mg/kg, B, E). The ellipse and polygonal dotted line in A outlines the area of the HN and DMN,
respectively. V, fourth ventricle; Scale bar = 100 μm.
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vagus of EGCG treated rats following PNCI
In sham-operated groups of the rats treated with or
without EGCG, hardly any detected NADPH-d/nNOS
(+) neurons were found either on the left or right side
of the DMN. From 3 days after PNCI, NADPH-d/nNOS
(+) neurons were detected and randomly distributed
throughout the injured DMN (Figures 2 and 3). There
were some shrunken cells expressing intense NADPH-d
at 14 days following PNCI (Figures 2 and 3). At the
same time, treatment with high doses of EGCG (25 and
50 mg/kg) tended to decrease the total number and per-
centage of NADPH-d/nNOS(+) neurons in the DMN
(462 ± 13 cell/u; 37.62 ± 1.09% and 433 ± 18 cell/u;
35.06 ± 1.31%, respectively) when compared with the
non-treatment one (628 ± 21 cell/u; 53.08 ± 0.91%;
Figure 4 and Table 1). The total number of NADPH-d
negative cells also showed a significantly increased in
EGCG-treated (25 and 50 mg/kg) rats after PNCI at
various time points (p < 0.05 vs. non-treated groups;
Table 1). Quantitative analysis of labeling intensity
showed stronger diaphorase reactivity in cells of non-
treated rats than those in rats treated with high-dose
EGCG (25 and 50 mg/kg) at 3, 7, and 14 days after
PNCI (p < 0.05, Figure 5). However, at 28 days after
PNCI, the percentage of NADPH-d(+) neurons on the
Figure 3 Immunohistochemistry of nNOS in the HN and DMN.
Light photomicrographs showing the nNOS reactivity in the
lesioned side of the HN and DMN at 7 (A, B, C) and 14 (D, E, F) days
after PNCI. nNOS staining is barely detected in HN and DMN
neurons in the contralateral intact side of the nuclei (the right side
of each figure), but significantly increased at 7 days in the affected
HN and DMN after PNCI (A, B, C). When compared with those at 7
days post PNCI, nNOS positive neurons in the HN are obviously
decreased in number at 14 days following PNCI, whereas those in
the DMN are inclined to increase (D, E, F). The immunoreactivities of
nNOS are markedly declined in the lesioned HN and DMN of rats
treated with high dose EGCG (50 mg/kg, C, F) in relation to those
of non-treated rats (A, D) or animals treated with lower dose EGCG
(10 mg/kg, B, E). Similarly, there were some nNOS intensely-labeled
neurons appear shrunken in contour (D, arrows) following PNCI. V,
fourth ventricle; Scale bar = 100 μm.
Figure 4 Alterations of NADPH-d reactivity in the HN and DMN
at 3, 7, 14 and 28 days after PNCI and EGCG treatment.
Quantitative analysis shows that PNCI causes a remarkably-increased
population of NADPH-d(+) neurons at different time intervals
examined. PNCI-induced NADPH-d(+) neurons reach their population
peak at 7 days in the HN but continue to increase their population in
the DMN until the end of the examination. Note a significant
decrease of NADPH-d(+) neurons in the groups receiving EGCG
treated animals when compared with those of non-treated (saline-
treated) ones at 7 and 14 days in the HN. At the same time intervals
in the DMN, the groups receiving high dosages of EGCG (25 and 50
mg/kg) show a marked reduction of NADPH-d(+) neuron population
when compared with those receiving lower dose of EGCG (10 mg/
kg) or saline. *, p < 0.05 for the comparison between EGCG-treated
and saline-treated groups at the same survival time point.
Wei et al. BMC Neuroscience 2011, 12:52
http://www.biomedcentral.com/1471-2202/12/52
Page 6 of 11crush injured side pretreated with 25 mg/kg EGCG was
similar to those with 10 mg/kg EGCG or none (p <0 . 0 5 ,
Figure 4). Moreover, there was no significant decline in
the total number, percentage or labeling intensity of
NADPH-d/nNOS(+) neurons in rats given a low-dose
(10 mg/kg) EGCG treatment (Figures 2B, E, 3B, E, 4 and
5; Table 1).
Cell population change of in the HN and DMN after EGCG
pretreatment and PNCI
In sham-operated rats irrespective of treatment, the
number of motor neurons in the HN and DMN (about
1400 and 1300 cell/u, respectively) at all time points
was not significantly different from that in the corre-
sponding nuclei of the opposite side. In non-treated rats
at 28 days following PNCI, about 18% and 26% neuro-
nal loss were respectively observed in the HN and
DMN (Table 2). However, in high-dose EGCG (25 and
50 mg/kg)-treated rats following PNCI, a significant
attenuation of neuronal loss (p <0 . 0 5 ,T a b l e2 )w a s
found when compared with those of nerve-crushed rats
treated with nothing or low-dose EGCG (10 mg/kg). No
contralateral (right) cell death was found in the sham-
operated groups as a consequence of unilateral (left)
nerve crush.
Discussion
T h ep r e s e n ts t u d yh a sp r o v i d e dt h ef i r s tm o r p h o l o g i c a l
evidence that EGCG treatment may reduce damage
caused by nerve crush-induced oxidative injury in brain-
stem motor neurons having different functions in adult
rats. The protective effect of EGCG on injured neurons
was dose-dependent. Taken together, our results suggest
that the protective effect of higher-dose EGCG may be
responsible for suppressing PNCI-induced NADPH-d/
n N O Se x p r e s s i o ni nt h eH Na n dD M Nb yi t sh i g h e r
antioxidant ability.
Role of NADPH-d/nNOS expression in motor neurons
after PNCI
The current study revealed induced expression of
NADPH-d/nNOS in the lower brainstem motor neurons
of adult rats following PNCI. At higher doses (25 and
50 mg/kg), EGCG significantly reduced the total number,
percentage and enzyme activity of cells expressing
NADPH-d/nNOS; this beneficial effect was more pro-
nounced with injury progress. Ultimately, this reduction in
NADPH-d/nNOS reactivity was markedly correlated with
the diminution of motor neuron loss at 7, 14, and 28 days
after PNCI. It is well documented that initial NO level and
the time of exposure to excess NO, generated by NOS via
the overstimulation of NMDA receptors, may account for
neuronal damage following PNI [45,46]. NO itself or per-
oxynitrite (ONOO
-), which is formed when NO couples
with the superoxide anion, can trigger a series of biochem-
ical reactions that culminate in damage to mitochondria,
nucleic acids, proteins, lipids, or DNA [9,47,48]. The coin-
cidence of overt lesion-induced NADPH-d/nNOS expres-
sion with the death of injured motor neurons has
therefore been found [14,49,50]. On the other hand, inhi-
bition of NOS production in mice following spinal root
avulsion has been shown to effectively reduce neuronal
death and enhance peripheral nerve regeneration
[14,15,51]. Our previous and other studies on the motor
neurons of adult rats have also shown that PNI along with
hypoxia or PNCI significantly up-regulated NADPH-d/
nNOS expression [17]. This up-regulation of enzyme
expression is due to the production of excess NO that has
detrimental effects on these neurons [23,27]. Interestingly,
preconditioning treatment with mild hypoxic may induce
Table 1 Effect of EGCG treatment on the total number of NADPH-d positive (+) and negative (-) cells in the lesioned
side of DMN and HN at 3, 7, 14 and 28 days following PNCI
Days postoperative Hypoglossal nucleus
Saline EGCG (10 mg/kg) EGCG (25 mg/kg) EGCG (50 mg/kg)
+-+-+ - + -
3 69 ± 4 1336 ± 7 65 ± 3 1343 ± 7 53 ± 4 1344 ± 9 31 ± 4* 1368 ± 7*
7 370 ± 9 924 ± 22 352 ± 11 952 ± 11 238 ± 10* 1121 ± 11* 114 ± 10* 1251 ± 16*
14 235 ± 9 963 ± 34 229 ± 11 1009 ± 29 79 ± 8* 1239 ± 10* 35 ± 7* 1296 ± 12*
28 43 ± 3 1122 ± 19 38 ± 4 1137 ± 31 6 ± 4* 1284 ± 6* 4 ± 3* 1297 ± 5*
Days postoperative Dorsal motor nucleus of vagus nerve
Saline EGCG (10 mg/kg) EGCG (25 mg/kg) EGCG (50 mg/kg)
+-+-+ - + -
3 368 ± 9 909 ± 6 351 ± 11 934 ± 8 283 ± 12* 1009 ± 18* 222 ± 9* 1067 ± 10*
7 628 ± 21 554 ± 3 590 ± 14 595 ± 9 462 ± 13* 765 ± 17* 433 ± 18* 802 ± 13*
14 616 ± 12 439 ± 20 599 ± 13 480 ± 17 580 ± 11 603 ± 19* 525 ± 17* 667 ± 18*
28 588 ± 16 363 ± 15 586 ± 11 397 ± 14 603 ± 14 418 ± 12* 608 ± 24 482 ± 17*
*, p < 0.05 when compared with the saline-treated group.
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and consequently protect against nerve crush-induced oxi-
dative injury. Thus, whether NO is protective or destruc-
tive depends on its amount: the small amount would
protect against neuronal damage and the large one cause
cell death. In the present study, moderate and transient
NADPH-d/nNOS expression was observed in the majority
of HN neurons with PNCI progression during which mild
neuronal death occurred. By contrast, NADPH-d/nNOS
expression in DMN motor neurons after PNCI was pro-
longed and cell loss was pronounced with injury develop-
ment (Figures 2, 3, and 7; Table 1 and 2). These results
implied a close association of NADPH-d/nNOS expression
with progressive neuronal death following PNCI. However,
in lack of experimental evidence, the assumption that
NADPH-d/nNOS positive neurons were the cells that died
after the nerve injury may not necessarily be the case. The
changes of NADPH-d or NOS activity may be part of a
dynamic response to injury rather than simply pathologi-
cally related.
Effects of EGCG on NADPH-d/nNOS expression in motor
neurons following PNCI
Our previous and other studies have shown that green tea,
melatonin, and hypoxic preconditioning strategies may
enhance endogenous antioxidative defense systems against
oxidative injury [20,22,23,26-28,52]. Green tea, rich in poly-
phenols, is one of the most widely consumed beverages in
the world. EGCG is the most abundant catechin in tea and
the major source of polyphenol bioactivity. Several studies
have indicated that the antioxidant activity of EGCG may
be neuroprotective and prevent NO-mediated neurological
deficits. In in vitro studies, EGCG can scavenge cytotoxic
NO or its downstream products [35,53]. The ability of
EGCG to protect against neuronal damage and brain
edema after unilateral cerebral ischemia and to reduce hip-
pocampal neuronal damage after transient global ischemia
in gerbils has been evidenced [54,55]. Our previous report
also showed that EGCG may impart the suppressive effect
on susceptibility of nodose neurons to nNOS-mediated
neuropathy subsequent to severe hypoxic exposure [26]. It
has been suggested that NO produced by nNOS and iNOS
plays an important role in pathophysiologic processes
including neurotoxicity and delayed neuronal death
[47,56]. Consequently, the amount of NOS reactivity may
be used as an index of neuronal damage severity. The pre-
sent results clearly indicated that high-doses EGCG (25
and 50 mg/kg) reduced NADPH-d/nNOS expression and
neuronal loss following PNCI that caused excessive and
prolonged expression of NADPH-d/nNOS leading to neu-
rodestruction in the region studied. Reducing the activity
of this enzyme (e.g., by treatment with EGCG) could
decrease neurological signs and neuronal damage as
reflected by evidences of our previous and other studies.
All these results showed that nNOS inhibitors, melatonin,
and high-doses EGCG (25 and 50 mg/kg) reduced nNOS
activity and neuronal damage after brain ischemia, hypoba-
ric hypoxia, and PNI [20,26,54,57]. Similarly, the present
study found that high-doses EGCG (25 and 50 mg/kg) may
be neuroprotective and thereby attenuate neuronal damage
after peripheral nerve crush injury.
Possible mechanisms regarding the differential responses
of different motor neurons to EGCG treatment after PNCI
Our previous and other studies found differences in PNI-
induced NADPH-d/nNOS expression between motor
Figure 5 Mean optical density (OD) of NADPH-d(+) neurons in
the HN and DMN of adult rats at 3, 7, 14 and 28 days after
PNCI and EGCG treatment. The changes of mean optical density
(determining staining intensity) in NADPH-d(+) neurons of
examined nuclei show a similar trend to the population
modification of labeled neurons. The OD value in the HN of high
dose EGCG-treated (25 and 50 mg/kg) animals is much lower than
those of low dose EGCG-treated (10 mg/kg) or non-treated ones at
7, 14 and 28 days after PNCI. The EGCG-mediated noticeable
decrease of NADPH-d optical density is also evidenced in the DMN
at different time points after PNCI. *, p < 0.05 for the comparison
between EGCG-treated and saline-treated groups at the same
survival time point.
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Page 8 of 11neurons having different functions, namely, somatic
efferents of the HN and visceral efferents of the DMN
[23,27]. In agreement with these findings, the present
results demonstrated a peak of PNCI-induced NADPH-
d/nNOS expression in motor neurons of the HN at 7
days, whereas those of the DMN persisted up to 28 days
(Figures 2, 3 and 4). This difference between the motor
neurons of the HN and DMN remains to be resolved but
may be due to differences in their regenerative capacity.
Previous tracing study with horseradish peroxidase
demonstrated that the majority of axotomized hypoglos-
sal motor neurons re-innervated tongue muscles at 14
days post-PNI [16]. During re-innervation, neurotrophic
factors may stimulate motor neuron regeneration and
thereby ensure the decrease in NADPH-d/nNOS expres-
sion in successful regenerating motor neurons [17,58,59].
Thus, to the extent that NADPH-d/nNOS expression is
correlated with the degree of functional recovery by
injured motor neurons, down-regulation of NADPH-d/
nNOS expression indicates a predictable functional
recovery of motor neurons in the crushed HN. Further-
more, the suppressive NADPH-d/nNOS expression seen
in rats treated with high-doses EGCG (25 and 50 mg/kg)
at all time points post-PNI implied that high-dose EGCG
facilitated functional recovery of the damaged HN. In
contrast, the current investigation also found that the
sustained expression of NADPH-d/nNOS in damaged
motor neurons of the DMN adversely affected their func-
tional recovery [17]. Our present evidences may echo the
finding that axonal regeneration appeared to be absent in
visceral motor neurons of the DMN [17]. However, in
view of the fact that the viability of surviving motor neu-
rons following PNI depended on their proximity to
injured axons [51,60], the injury sites of the hypoglossal
and vagus nerves should be seriously considered. In our
present study, the nerve crush at the cervical level of the
vagus nerve relative to that of the hypoglossal nerve may
have been proximal enough to cause severe damage to
DMN motor neurons.
Conclusion
T h ec u r r e n ts t u d yd e m o n s t r a t e dm o r p h o l o g i c a l l ya n d
quantitatively that high-doses (25 and 50 mg/kg) EGCG
can reduce PNCI-induced NADPH-d/nNOS expression in
the HN and DMN motor neurons. This novel finding not
only improved our understanding of the functional role of
NO in neuronal damage, but also provided an EGCG neu-
roprotective strategy to suppress nNOS-mediated toxicity
in the HN and DMN motor neurons damaged by PNCI.
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